Reply to the letter to the editor 'Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial' by Ceccarelli et al Journal Article


Author: Lacouture, M. E.
Article Title: Reply to the letter to the editor 'Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial' by Ceccarelli et al
Keywords: carcinoma, non-small-cell lung; lung neoplasms; lung tumor; probiotic agent; non small cell lung cancer; probiotics; dacomitinib; humans; human; quinazolinones; quinazolinone derivative
Journal Title: Annals of Oncology
Volume: 27
Issue: 11
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2016-11-01
Start Page: 2138
End Page: 2139
Language: English
PUBMED: 27664149
PROVIDER: scopus
PMCID: 27664149
DOI: 10.1093/annonc/mdw403
DOI/URL:
Notes: Letter -- Export Date: 1 February 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture